TITLE

Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility?

AUTHOR(S)
V Goh; S Halligan; L Gartner; P Bassett; BAI Bartram
PUB. DATE
July 2006
SOURCE
British Journal of Radiology;Jul2006, Vol. 79 Issue 943, p578
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The purpose of this study was to determine if greater z-axis tumour coverage improves the reproducibility of quantitative colorectal cancer perfusion measurements using CT. A 65 s perfusion study was acquired following intravenous contrast administration in 10 patients with proven colorectal cancer using a four-detector row scanner. This was repeated within 48 h using identical technical parameters to allow reproducibility assessment. Quantitative tumour blood volume, blood flow, mean transit time and permeability measurements were determined using commercially available software (Perfusion 3.0; GE Healthcare, Waukesha, WI) for data obtained from a 5 mm z-axis tumour coverage, and from a 20 mm z-axis tumour coverage. Measurement reproducibility was assessed using Bland-Altman statistics, for a 5 mm z-axis tumour coverage, and 20 mm z-axis tumour coverage, respectively. The mean difference (95% limits of agreement) for blood volume, blood flow, mean transit time and permeability were 0.04 (-2.50 to +2.43) ml/100 g tissue; +8.80 (-50.5 to +68.0) ml/100 g tissue/min; -0.99 (-8.19 to +6.20) seconds; and +1.20 (-5.42 to +7.83) ml/100 g tissue/min, respectively, for a 5 mm coverage, and -0.04 (-2.61 to +2.53) ml/100 g tissue; +7.40 (-50.3 to +65.0) ml/100 g tissue/min; -2.46 (-12.61 to +7.69) seconds; and -0.23 (-8.31 to +7.85) ml/100 g tissue/min, respectively, for a 20 mm coverage, indicating similar levels of agreement. In conclusion, increasing z-axis coverage does not improve reproducibility of quantitative colorectal cancer perfusion measurements.
ACCESSION #
22240794

 

Related Articles

  • Impact of hospital case volume on short-term outcome after laparoscopic operation for colonic cancer. Kuhry, E.; Bonjer, H J; Haglind, E; Hop, W C J; Veldkamp, R; Cuesta, M A; Jeekel, J; PĂ„hlman, L; Morino, M; Lacy, A; Delgado, S; COLOR Study Group // Surgical Endoscopy;May2005, Vol. 19 Issue 5, p687 

    Background: High hospital case volume has been associated with improved outcome after open operation for colorectal malignancies.Methods: To assess the impact of hospital case volume on short-term outcome after laparoscopic operation for colon cancer, we conducted an...

  • Results of Cancer Care Quality Study Lead to Cautious Optimism, Caveats. Christensen, Damaris // JNCI: Journal of the National Cancer Institute;8/4/2004, Vol. 96 Issue 15, p1124 

    Reports on the findings of a study about the quality of care received by cancer patients in the United States. Medical treatment of people with breast or colorectal cancer; Gaps in the quality of cancer care; Surgical care.

  • Virtual colonoscopy aimed to improve patient reluctance.  // Hudson Valley Business Journal;11/15/2004, Vol. 15 Issue 23, p23 

    The article informs that Colon cancer is the second deadliest cancer in the United States. The thought of being screened for colon cancer does bring reluctance but it is important for adults 50 years and older to get screened for colon cancer. CT Virtual Colonoscopy is seen as an alternative to...

  • Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. Brandi, G.; Pantaleo, M. A.; Calabrese, C.; Di Battista, M.; Poggi, R.; Bajetta, E.; Biasco, G. // International Journal of Colorectal Disease;Nov2004, Vol. 19 Issue 6, p599 

    Background and aims: The best treatment of patients with advanced colorectal cancer at the time of diagnosis is not well known, and the medical treatment is still unsatisfactory. Case presentation: We report the case of a patient showing a complete remission of primary tumor after medical...

  • Colorectal cancer in patients from Uganda: A histopathological study. Dijxhoorn, D. N.; Boutall, A.; Mulder, C. J.; Ssebuufu, R.; Mall, A.; Kalungi, S.; Baigrie, C.; Goldberg, P. A. // East & Central African Journal of Surgery;Mar/Apr2014, Vol. 19 Issue 1, p112 

    Background: Approximately one million people are diagnosed with colorectal cancer (CRC) globally each year. Uganda is a developing country with an estimated total population of 32.9 million. The incidence of colorectal cancer is reported to be low. The clinical impression is that it occurs...

  • Adjuvant and neoadjuvant treatment for rectal cancer, colon cancer, and non-small-cell lung cancer in older patients. Rahal, R.; Porter, G.; Forte, T.; Fung, S.; Bryant, H. // Current Oncology;Aug2014, Vol. 21 Issue 4, p193 

    The article focuses on the adjuvant and neoadjuvant treatment focused on rectal cancer, colon cancer and lung cancer in old patients. It mentions that evidence-based treatment guidelines focused on improving the quality of care patients based on randomized controlled trials. It focuses on...

  • A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer. Pelley, Robert; Ganapathi, Ram; Wood, Laura; Rybicki, Lisa; McLain, Denise; Budd, G. Thomas; Peereboom, David; Olencki, Thomas; Bukowski, Ronald M. // Cancer Chemotherapy & Pharmacology;Sep2000, Vol. 46 Issue 3, p251 

    Purpose: To perform a phase II trial of pyrazoloacridine (PZA), a novel DNA intercalator, in patients with metastatic colorectal carcinoma and no previous therapy. Methods: PZA was administered at a dose of 750 mg/m2 intravenously over 3 h every 21 days. Pharmacokinetic studies to determine PZA...

  • Palliative Chemotherapy in Advanced Colorectal Cancer. Walling, Anne D. // American Family Physician;3/1/2001, Vol. 63 Issue 5, p957 

    Presents information on a study conducted by the European Colorectal Cancer Collaborative Group, which analyzed data from multiple sources to determine the benefits and harms of palliative chemotherapy in patients with locally advanced or metastatic colorectal cancer and to compare the outcomes...

  • Two-week rule a failure'.  // Pulse;7/19/2007, Vol. 67 Issue 28, p13 

    The article focuses on the significance of the two-week referral rule among the cancer patients in Great Britain. Study shows that the rule is failing cancer patients referred through both the fast-track and the routine pathways. It tends to overwhelm hospitals with inappropriate referrals and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics